Potential augmentation of terlipressin antidiuretic effects by gabapentinoids

J Hepatol. 2024 Aug;81(2):e71-e73. doi: 10.1016/j.jhep.2024.02.015. Epub 2024 Feb 23.

Authors

Penelope N Markham¹, Jasmohan S Bajaj², Paul J Thuluvath³, David Koch⁴, Joseph Palumbo⁵

Affiliations

¹ BioVie Inc., Carson City, Nevada, USA. Electronic address: [email protected].
² Richmond VA Medical Center, Richmond, Virginia, USA; Virginia Commonwealth University, Richmond, Virginia, USA.
³ Mercy Medical Center, Baltimore, Maryland, USA; University of Maryland School of Medicine, Baltimore, Maryland, USA.
⁴ The Medical University of South Carolina, Charleston, South Carolina, USA.
⁵ BioVie Inc., Carson City, Nevada, USA.

PMID: 38403026
DOI: 10.1016/j.jhep.2024.02.015

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Gabapentin / administration & dosage
Gabapentin / therapeutic use
Humans
Lypressin / administration & dosage
Lypressin / adverse effects
Lypressin / analogs & derivatives
Male
Terlipressin* / administration & dosage
Vasoconstrictor Agents / administration & dosage
Vasoconstrictor Agents / adverse effects

Substances

Terlipressin
Gabapentin
Vasoconstrictor Agents
Lypressin